During the past decade, Clinica de Alergia Martti Antila conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinica de Alergia Martti Antila" are "Asthma" (1 trials), "Cold" (1 trials) and "Flu Symptom" (1 trials). Many other conditions were trialed in "Clinica de Alergia Martti Antila" in a lesser frequency.

Most popular intervention types in "Clinica de Alergia Martti Antila" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alenia" (1 trials), "Experimental drug (paracetamol 500mg / fexofenadine 60mg / phenylephrine 20mg)" (1 trials), "Foraseq" (1 trials), "Formoterol/Budesonide" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica de Alergia Martti Antila" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Clinica de Alergia Martti Antila". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Clinica de Alergia Martti Antila, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinica de Alergia Martti Antila, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".